Skip to main content

Medical Solutions to Distribute Empire Genomics' Genotyping Technology

NEW YORK (GenomeWeb News) – Medical Solutions will be the exclusive UK distributor and service provider for Empire Genomics’ AccuArray array comparative genomic hybridization genotyping technology under an alliance announced today.
 
In addition to distributing the technology, Nottingham, UK-based Medical Solutions said that it would offer genotyping services, including in-house bioinformatics analysis and support, using the technology in its labs. The AccuArray also has applications in clinical diagnostics and pharmacogenetic testing, the firms said.
 
“The diagnostic capability of this assay is of particular interest to those groups in the healthcare community involved in cytogenetic and pre- and post-natal testing,” Tom Weaver, commercial director for Medical Solutions, said in a statement.
 
He said the AccuArray aCGH could be used to identify genetic aberrations linked with several diseases and conditions, such as cancer, autism, Alzheimer’s, several congenital abnormalities, and Down Syndrome.
 
Terms of the alliance were not disclosed.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.